Orthofix International Overview
- Year Founded
-
1980
- Status
-
Public
- Employees
-
1,616
- Stock Symbol
-
OFIX
- Investments
-
12
- Share Price
-
$16.29
- (As of Wednesday Closing)
Orthofix International General Information
Description
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Contact Information
Website
www.orthofix.comCorporate Office
- 3451 Plano Parkway
- Lewisville, TX 75056
- United States
Corporate Office
- 3451 Plano Parkway
- Lewisville, TX 75056
- United States
Orthofix International Timeline
Orthofix International Stock Performance
As of 26-Mar-2025, Orthofix International’s stock price is $16.29. Its current market cap is $635M with 39M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.29 | $16.51 | $12.08 - $20.73 | $635M | 39M | 198K | -$3.30 |
Orthofix International Financials Summary
As of 31-Dec-2024, Orthofix International has a trailing 12-month revenue of $799M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 774,401 | 774,401 | 551,224 | 379,223 |
| Revenue | 799,491 | 799,491 | 746,641 | 460,713 |
| EBITDA | (34,144) | (34,144) | (86,948) | 15,657 |
| Net Income | (125,997) | (125,997) | (151,395) | (19,749) |
| Total Assets | 893,294 | 893,294 | 925,315 | 458,629 |
| Total Debt | 179,628 | 179,628 | 117,074 | 21,529 |
Orthofix International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Orthofix International Comparisons
Industry
Financing
Details
Orthofix International Competitors (15)
One of Orthofix International’s 15 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| NuVasive | Formerly VC-backed | San Diego, CA | ||||
| TELA Bio | Formerly VC-backed | Malvern, PA | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| OrthoPediatrics | Formerly VC-backed | Warsaw, IN |
Orthofix International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Orthofix International Investments & Acquisitions (12)
Orthofix International’s most recent deal was a Later Stage VC with nView Medical for . The deal was made on 31-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| nView Medical | 31-Dec-2024 | Later Stage VC | Surgical Devices | ||
| SeaSpine Holdings | 05-Jan-2023 | Merger/Acquisition | Therapeutic Devices | ||
| Legion Innovations (intellectual property rights) | 29-Dec-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Neo Medical (Surgical Devices) | 22-Sep-2020 | Later Stage VC | Surgical Devices | ||
| Wittenstein (Fitbone Limb Lengthening System in Igersheim, Germany) | 26-Mar-2020 | Corporate Asset Purchase | Buildings and Property |
Orthofix International ESG
Risk Overview
Risk Rating
Updated June, 04, 2024
26.68 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Devices
Subindustry
of 196
Rank
Percentile
Orthofix International Exits (1)
Orthofix International’s most recent exit was on 01-Nov-2003 from Breg. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Breg | 01-Nov-2003 | Completed |
|
Orthofix International Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SeaSpine Holdings | Carlsbad, CA | 2002 | |
| Orthofix Australia |
Orthofix International FAQs
-
When was Orthofix International founded?
Orthofix International was founded in 1980.
-
Where is Orthofix International headquartered?
Orthofix International is headquartered in Lewisville, TX.
-
What is the size of Orthofix International?
Orthofix International has 1,616 total employees.
-
What industry is Orthofix International in?
Orthofix International’s primary industry is Surgical Devices.
-
Is Orthofix International a private or public company?
Orthofix International is a Public company.
-
What is Orthofix International’s stock symbol?
The ticker symbol for Orthofix International is OFIX.
-
What is the current stock price of Orthofix International?
As of 26-Mar-2025 the stock price of Orthofix International is $16.29.
-
What is the current market cap of Orthofix International?
The current market capitalization of Orthofix International is $635M.
-
What is Orthofix International’s current revenue?
The trailing twelve month revenue for Orthofix International is $799M.
-
Who are Orthofix International’s competitors?
Globus Medical, NuVasive, TELA Bio, Zimmer Biomet Holdings, and OrthoPediatrics are some of the 15 competitors of Orthofix International.
-
What is Orthofix International’s annual earnings per share (EPS)?
Orthofix International’s EPS for 12 months was -$3.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
